NEWS

New Migraine Treatment Through Electrical Stimulation of Vagus Nerve

May 1 2022
NEWS
New Migraine Treatment Through Electrical Stimulation of Vagus Nerve
May 1 2022

New Migraine Treatment Through Electrical Stimulation of Vagus Nerve

NEWS

gammaCore™ (nVNS) is the first non-invasive, hand-held therapy applied at the neck to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without gammaCore the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. gammaCore (nVNS) is a FDA cleared prescription therapy in the United States for adjunctive use for the preventive treatment i of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients, and paroxysmal hemicrania and hemicrania continua in adult patients.

To receive more information go to www.bit.ly/GammaCore